agilon health inc. Financial Statements
NYSE: AGLHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
agilon health inc. revenue and earnings
In fiscal 2025, agilon health inc. generated $5.93 billion in revenue, down 2.1% from fiscal 2024, the first decline in the 7 years shown. agilon health inc. reported a net loss of $391.3 million, compared with a loss of $260.2 million a year earlier. Operating margin was -7.8%.
Diluted earnings per share came in at -$0.98. Over the last 5 fiscal years, AGL's revenue has grown at a 37.2% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
agilon health inc. income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Revenue | 5.93B | 6.06B | 4.32B | 2.39B | 1.52B | 1.22B | 794.41M |
| Revenue growth (YoY) | -2.11% | +40.41% | +80.74% | +56.97% | +24.88% | +53.36% | — |
| Operating Expenses | — | — | — | 2.83B | 2.23B | 1.28B | 900.99M |
| Operating Income | -463.24M | -292.13M | -232.13M | -105.38M | -372.24M | -56.67M | -106.57M |
| Interest Expense | 6.64M | 6.18M | 6.66M | 4.48M | 6.15M | 8.13M | 9.07M |
| Other Income (Expense) | 67.62M | 34.49M | 27.84M | 13.93M | 2.18M | 2.46M | 955.00K |
| Pretax Income | -404.10M | -248.83M | -194.46M | -90.67M | -382.98M | -62.34M | -114.69M |
| Income Tax | 1.25M | 1.45M | 791.00K | 1.64M | 886.00K | 865.00K | -232.00K |
| Net Income | -391.35M | -260.15M | -262.60M | -106.55M | -406.49M | -60.05M | -282.59M |
| Net Income growth (YoY) | — | — | — | — | — | — | — |
| EPS (Basic) | -0.98 | -0.61 | -0.48 | -0.22 | -1.03 | -0.20 | — |
| EPS (Diluted) | -0.98 | -0.61 | -0.48 | -0.22 | -1.03 | -0.20 | — |
| Shares Outstanding (Basic) | 413.97M | 410.97M | 408.92M | 408.15M | 372.93M | 323.46M | 294.74M |
| Shares Outstanding (Diluted) | 413.97M | 410.97M | 408.92M | 408.15M | 372.93M | 323.46M | 294.74M |
| EBITDA | -434.64M | -267.67M | -211.97M | -91.61M | -357.57M | -42.57M | -65.16M |
| Operating Margin | -7.81% | -4.82% | -5.38% | -4.41% | -24.47% | -4.65% | -13.42% |
| Net Margin | -6.60% | -4.29% | -6.08% | -4.46% | -26.72% | -4.93% | -35.57% |
This table shows 7 annual periods of agilon health inc.'s income statement, from FY 2025 back to FY 2019, across 15 line items including revenue, operating expenses, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow AGL's reporting calendar. What is a income statement?